RESPONSE OF HUMAN ENDOMETRIUM AND OVARIAN-CARCINOMA CELL-LINES TO PHOTODYNAMIC THERAPY

被引:17
|
作者
RAAB, GH
SCHNEIDER, AF
EIERMANN, W
GOTTSCHALKDEPONTE, H
BAUMGARTNER, R
BEYER, W
机构
[1] UNIV MUNICH,KLINIKUM GROSSHADERN,DEPT GYNECOL,MARCHIONISTR 15,W-8000 MUNICH 70,GERMANY
[2] GESELL STRAHLEN & UMWELTFORSCH MBH,CENT LASER LAB,MUNICH NEUHERBERG,GERMANY
关键词
Cell culture; Gynecological tumors; Photodynamic therapy; Photosensitizer;
D O I
10.1007/BF02389584
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
The response of the human gynecological carcinoma cell-lines HEC-1-A (endometrial carcinoma) and OvCar-3 (ovarian carcinoma) to photodynamic therapy in vitro was examined. The porphyrin compound Photosan III® (Ph III) was used for photosensitization of the cells after incubation times of 24 h (HEC-1-A) and 48 h (HEC-1-A and OvCar-3). The Ph III doses varied from 0-10 μg/ml medium. Irradiation was performed with laser light at 630 nm. Irradiation doses up to 20 J/cm2 were applied at an irradiance of 40-100 mW/cm2. Cell vitality of the untreated control groups and of the therapy group was determined 48 h after irradiation, using the trypan blue exclusion test. The experimental results show that treatment of OvCar-3 cells with 10 J/cm2 resulted in a decrease in vitality dependent on photosensitizer dose (0-5 μg/ml, 48 h incubation time) but independent of the irradiance (40-100 mW/cm2). Complete cell death was observed after application of irradiation doses in the range of 5-20 J/cm2 combined with drug concentrations of 10-2.5 μg/ml, at a fixed incubation time of 48 h. HEC-1-A cells did not survive photodynamic therapy with 10 J/cm2 after incubation with 5 μg/ml for 48 h. After a shorter incubation time of 24 h, 10 μg/ml Ph III was necessary for the same effect. There was a maximum decrease in cell vitality when measured 48 h after irradiation. This was not improved at 72 h. © 1990 Springer-Verlag.
引用
收藏
页码:13 / 20
页数:8
相关论文
共 50 条
  • [1] EFFECTS OF BIOLOGICAL RESPONSE MODIFIERS ON OVARIAN-CARCINOMA CELL-LINES
    MARTH, C
    HELMBERG, M
    MAYER, I
    FUITH, LC
    DAXENBICHLER, G
    DAPUNT, O
    [J]. ANTICANCER RESEARCH, 1989, 9 (02) : 461 - 467
  • [2] CYTOGENETIC ANALYSIS OF 4 HUMAN OVARIAN-CARCINOMA CELL-LINES
    SHEER, D
    SHEPPARD, DM
    GORMAN, PA
    WARD, B
    WHELAN, RDH
    HILL, BT
    [J]. CANCER GENETICS AND CYTOGENETICS, 1987, 26 (02) : 339 - 349
  • [3] CHARACTERIZATION OF 2 NEW HUMAN OVARIAN-CARCINOMA CELL-LINES
    SINNA, GA
    BECKMAN, G
    LUNDGREN, E
    NORDENSON, I
    ROOS, G
    [J]. GYNECOLOGIC ONCOLOGY, 1979, 7 (03) : 267 - 280
  • [4] IMMUNOTOXINS DIRECTED AGAINST HUMAN OVARIAN-CARCINOMA CELL-LINES
    PIRKER, R
    FITZGERALD, DJP
    WILLINGHAM, MC
    LUDWIG, H
    PASTAN, I
    [J]. BLUT, 1987, 55 (04): : 261 - 261
  • [5] MECHANISMS OF CISPLATIN CYTOTOXICITY IN HUMAN OVARIAN-CARCINOMA CELL-LINES
    SHELLARD, S
    HOSKING, L
    FICHTINGERSCHEPMAN, AM
    HILL, BT
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1990, 18 (04) : 622 - 622
  • [6] ESTABLISHMENT AND CHARACTERIZATION OF 4 HUMAN EPITHELIAL OVARIAN-CARCINOMA CELL-LINES
    HIRTE, HW
    KAISER, JS
    BACCHETTI, S
    [J]. CANCER, 1994, 74 (03) : 900 - 906
  • [7] EXPRESSION OF A HUMAN MULTIDRUG RESISTANCE GENE IN HUMAN OVARIAN-CARCINOMA CELL-LINES
    SEKIYA, S
    NUNOYAMA, T
    SHIRASAWA, H
    KIMURA, H
    KAWATA, M
    IIJIMA, N
    SUGIMOTO, Y
    TSURUO, T
    TAKAMIZAWA, H
    [J]. ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 1992, 251 (02) : 79 - 86
  • [8] CELLULAR HETEROGENEITY OF CELL-LINES FROM AN OVARIAN-CARCINOMA
    CHAO, KC
    NG, HT
    CHANG, CC
    HU, CP
    CHANG, CM
    [J]. TUMOR BIOLOGY, 1987, 8 (06) : 295 - 296
  • [9] DIFFERENTIAL MODULATION OF CISPLATIN CYTOTOXICITY BY HUMAN OVARIAN-CARCINOMA CELL-LINES INVITRO
    SHELLARD, SA
    FICHTINGERSCHEPMAN, AMJ
    HOSKING, LK
    HILL, BT
    [J]. BIOCHEMICAL SOCIETY TRANSACTIONS, 1991, 19 (02) : S126 - S126
  • [10] CYTOGENETIC FINDINGS IN OVARIAN CELL-LINES DERIVED FROM OVARIAN-CARCINOMA
    SMITH, A
    DENDULK, G
    DAY, CV
    TATTERSALL, MHW
    RUSSELL, P
    [J]. AUSTRALIAN PAEDIATRIC JOURNAL, 1985, 21 (04): : 317 - 317